S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 

Intra-Cellular Therapies (ITCI) SEC Filings & 10K Form

Notice: Trading of Intra-Cellular Therapies halted at 06:55 AM EST due to "News pending".
$79.84
+15.08 (+23.29%)
(As of 04/16/2024 ET)

Recent Intra-Cellular Therapies SEC Filings

DateFilerForm TypeView
04/02/2024
3:15 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
3:15 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
4:15 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:44 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:31 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:31 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:32 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:33 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:33 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
3:52 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:38 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:45 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:30 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/11/2024
3:30 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
4:58 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:58 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:58 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:59 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:59 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:44 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
3:36 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/07/2024
3:27 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2024
6:04 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:05 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
6:41 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:57 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:58 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:58 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
6:59 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
7:00 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
7:00 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:22 PM
Intra-Cellular Therapies (Subject)
VAN NOSTRAND ROBERT L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:46 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:46 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:33 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2024
3:22 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/22/2024
6:39 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2024
6:42 AM
Intra-Cellular Therapies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/09/2024
11:40 AM
Intra-Cellular Therapies (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.
02/05/2024
5:02 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:07 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:10 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2024
5:13 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:47 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:39 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
3:41 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
6:47 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
4:08 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/12/2024
5:02 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:45 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/04/2024
6:54 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:43 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2024
5:46 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:38 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
10:15 AM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:52 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2023
4:31 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2023
3:15 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2023
12:06 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/02/2023
7:01 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/02/2023
7:01 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2023
4:29 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2023
4:30 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
7:40 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2023
3:13 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2023
3:13 PM
Intra-Cellular Therapies (Subject)
Mates Sharon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/13/2023
3:18 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2023
3:40 PM
Alexandria Venture Investments, LLC (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2023
5:05 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2023
5:09 PM
Intra-Cellular Therapies (Subject)
Neumann Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/03/2023
6:39 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/03/2023
6:44 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/20/2023
4:47 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/17/2023
3:13 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/07/2023
5:07 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4/A
07/07/2023
5:07 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4/A
07/07/2023
5:08 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4/A
07/05/2023
3:30 PM
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/05/2023
3:30 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:11 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:11 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:12 PM
Intra-Cellular Therapies (Issuer)
Salas Eduardo Rene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
4:12 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2023
4:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2023
3:28 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/04/2023
6:45 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2023
6:37 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2023
5:00 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ITCI) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners